| DSPN | distal sensory polyneuropathy; distal symmetrical polyneuropathy |
|---|---|
| FAP | Familial Amyloid Polyneuropathy |
| GBS | 1) Guillain-Barr Syndrome = PIP; Post-Infectious Polyneuropat... |
| ACIP | acute canine idiopathic polyneuropathy; Advisory Committee on Immunization Practices [CDC] |
| AIDP | acute idiopathic demyelinating polyneuropathy |
| AIDP | Acute inflammatory demyelinating polyneuropathy |
|---|---|
| CIDP | Chronic Inflammatory Demyelinating Polyneuropathy |
| CIP | Critical illness polyneuropathy |
| FAP | Familial Amyloid Polyneuropathy |
| FAP | Familial Amyloidotic Polyneuropathy |
| carcinomatous | Pertaining to or manifesting the characteristic properties of carcinoma. (05 Mar 2000) |
|---|---|
| carcinomatous encephalomyelopathy | An encephalomyelopathy as a remote effect of carcinoma, most often oat cell carcinoma of the lung; characterised by extensive nerve cell loss, which may be diffuse, but often predominates in particular portions of the central nervous system, particularly the limbic lobes, medulla, cerebellum, and gray matter of the spinal cord. Synonym: carcinomatous encephalomyelopathy, encephalomyelitis associated with carcinoma, paracarcinomatous encephalomyelopathy. (05 Mar 2000) |
| carcinomatous implants | Transference of carcinoma cells from a primary tumour to adjacent tissues where growth continues. (05 Mar 2000) |
| carcinomatous myelopathy | Degeneration or necrosis of the spinal cord associated with a carcinoma. Synonym: paracarcinomatous myelopathy. (05 Mar 2000) |
| carcinomatous myopathy | <syndrome> A condition characterised by muscle weakness that is similar to the symptoms of myasthenia gravis. For this reason, it has been referred to as myasthenic syndrome. This disorder is caused by an insufficient release of neurotransmitter (acetylcholine) by the nerve cells. Unlike myasthenia gravis, as muscle contractions are continued, strength will increase. The cause of Lambert-Eaton syndrome is unknown, but is usually associated with small cell carcinoma of the lung or an autoimmune illness. (27 Sep 1997) |
| carcinomatous neuromyopathy | Neuromyopathy associated with carcinoma, especially of the lung. (05 Mar 2000) |
| carcinomatous pericarditis | Pericarditis due to infiltration of carcinomatous cells, usually from surrounding structures. (05 Mar 2000) |
| acute demyelinating polyneuropathy | <neurology> A neurologic condition. Synonym: Guillain-Barre syndrome. Origin: Gr. Pathos = disease (27 Sep 1997) |
| acute inflammatory polyneuropathy | <neurology, syndrome> Acute infective polyneuritis that results in a form of peripheral neuropathy with temporary loss of movement and sensation due to inflammation of multiple nerves and loss of myelin. The exact cause is unknown but has been associated with an abnormal immune response to viral infection, particularly cytomegalovirus infection, in which there is cell-mediated immunity to a component of myelin. The disease may be autoimmune in origin and complete recovery can take up to six months. Synonym: Guillain-Barre syndrome (12 Jul 2000) |
| alcoholic polyneuropathy | <neurology> A disorder that occurs secondary to the damage to nerve cells from habitual alcohol abuse. The effects of alcoholic polyneuropathy may be due in part to the direct toxic effect alcohol has on nervous tissue in combination with specific nutritional deficiencies (for example B1 or thiamin deficiency and B12 deficiency). Common symptoms include sensory changes, numbness, tingling, muscle weakness, muscle cramps, heat intolerance, impotence, difficulty urinating, swallowing difficulty, speech impairment, diarrhoea and constipation. Origin: Gr. Pathos = disease (27 Sep 1997) |
| arsenical polyneuropathy | An axon loss polyneuropathy that results from subacute or chronic arsenic poisoning; almost always preceded by gastrointestinal symptoms; one of the heavy metal neuropathies. (05 Mar 2000) |
| axonal polyneuropathy | A type of polyneuropathy in which axon degeneration is the sole/predominant feature; many aetiologies, particularly toxic and metabolic; on nerve conduction studies, affects amplitudes of the responses, but does not cause conduction slowing or block. Synonym: axonal polyneuropathy. (05 Mar 2000) |
| axon loss polyneuropathy | A type of polyneuropathy in which axon degeneration is the sole/predominant feature; many aetiologies, particularly toxic and metabolic; on nerve conduction studies, affects amplitudes of the responses, but does not cause conduction slowing or block. Synonym: axonal polyneuropathy. (05 Mar 2000) |
| buckthorn polyneuropathy | Ascending polyneuropathy resulting from ingestion of the fruit of Karwinskia humboldtiana. (05 Mar 2000) |
| chronic inflammatory demyelinating polyneuropathy | An uncommon, acquired, demyelinating sensorimotor polyneuropathy, clinically characterised by insidious onset, and slow evolution, (either steady progression or stepwise), and chronic course; symmetrical weakness is a predominant symptom, often involving proximal leg muscles, accompanied by paresthesias, but not pain; CSF examination shows elevated protein, while electrodiagnostic studies reveal evidence of a demyelinating process, primarily conduction slowing rather than block; sometimes responds to prednisone. (05 Mar 2000) |
| carcinomatous polyneuropathy |
paraneoplastic polyneuropathy seen with carcinoma, especially of the lung; it consists of sensory and sensorimotor disturbances such as dysesthesias, paresthesias, and unsteadiness of gait. Cf. carcinomatous neuromyopathy.
출처: www.mercksource.com/pp/us/cns/cns_hl_dorlands.jspz...
|
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|